Katrina Miller, a science reporter for The New York Times, discusses historic cuts to National Science Foundation funding, exploring the impact on research and the future of STEM initiatives. Accompanying her is Dr. Jason Karlawish, a Professor of Medicine at the University of Pennsylvania, who reveals a groundbreaking FDA-approved blood test for Alzheimer’s, which measures amyloid and tau proteins. Their conversation addresses not only the financial strain on science but also the exciting advancements in Alzheimer’s diagnosis that could change patient care.
